Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Loss of BRCA1 p220 function is linked to basal-like breast cancer (BLBC), but the mechanism remains unclear.
• BRCA1 collaborates with NUMB and HES1 in mammary epithelial cells (MECs) for DNA repair and differentiation control.
• Unrepaired DNA damage can induce transdifferentiation to mesenchymal states in MECs.

Purpose of the Study:

• To elucidate the mechanism by which BRCA1 loss drives basal-like breast cancer.
• To investigate the role of DNA damage and transdifferentiation in BRCA1-deficient breast cancer development.
• To understand the cellular evolution from normal MECs to tumor cells in BRCA1-associated BLBC.

Main Methods:

• Studied the function of BRCA1, NUMB, and HES1 in mammary epithelial cells (MECs).
• Utilized chemically induced interstrand crosslink (ICL) damage in murine MECs.
• Performed in vivo single-cell analysis to track cellular evolution during tumor development.

Main Results:

• Loss of BRCA1, NUMB, or HES1, or induced ICL damage, causes persistent DNA damage and luminal to basal/mesenchymal transdifferentiation in murine MECs.
• In vivo single-cell analysis showed a time-dependent progression from normal luminal MECs to basal/mesenchymal tumor cells during BRCA1 BLBC development.
• Increasing DNA damage correlated with malignant transformation in BRCA1-deficient murine models.

Conclusions:

• Persistent DNA damage and subsequent transdifferentiation are key mechanisms in BRCA1-associated basal-like breast cancer.
• BRCA1 plays a critical role in maintaining genomic stability and normal cell differentiation in MECs.
• Understanding these pathways offers potential targets for BLBC treatment.